PHARMACYTE BIOTECH, INC. (PMCB) Share buybacks
- Total buybacks · last 12 months (USD): Value $401.63K; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-04-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-04-30..
Share buybacks
Overview →Financial period ending 2026-04-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $401.63K | Trailing-year cash paid for share repurchases. Period ending 2026-04-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-04-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 401.63K USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-04-30 | $401.63K | (m) | (m) |
| 2026-01-31 | $573.17K | (m) | (m) |
| 2025-10-31 | $396.57K | (m) | (m) |
| 2025-07-31 | $1.80M | (m) | (m) |
| 2025-04-30 | $2.54M | (m) | (m) |
| 2025-01-31 | $3.55M | (m) | (m) |
| 2024-10-31 | $3.72M | (m) | (m) |
| 2024-07-31 | $2.48M | (m) | (m) |
| 2024-04-30 | $28.20M | (m) | (m) |
| 2024-01-31 | $31.33M | (m) | (m) |
| 2023-10-31 | $34.71M | (m) | (m) |
| 2023-07-31 | $37.93M | (m) | (m) |
| 2023-04-30 | $13.56M | (m) | (m) |
| 2023-01-31 | (m) | (m) | (m) |
| 2022-10-31 | (m) | (m) | (m) |
| 2022-07-31 | (m) | (m) | (m) |
| 2022-04-30 | $0.00 | (m) | (m) |
| 2022-01-31 | (m) | (m) | (m) |
| 2021-10-31 | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |